Literature DB >> 16442673

Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice.

M Lucrecia Alvarez1, Heidi L Pinyerd, Jason D Crisantes, M Manuela Rigano, Julia Pinkhasov, Amanda M Walmsley, Hugh S Mason, Guy A Cardineau.   

Abstract

Yersinia pestis, the causative agent of plague, is an extremely virulent bacterium but there are no approved vaccines for protection against it. Our goal was to produce a vaccine that would address: ease of delivery, mucosal efficacy, safety, rapid scalability, and cost. We developed a novel production and delivery system for a plague vaccine of a Y. pestis F1-V antigen fusion protein expressed in tomato. Immunogenicity of the F1-V transgenic tomatoes was confirmed in mice that were primed subcutaneously with bacterially-produced F1-V and boosted orally with transgenic tomato fruit. Expression of the plague antigens in fruit allowed producing an oral vaccine candidate without protein purification and with minimal processing technology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442673     DOI: 10.1016/j.vaccine.2005.12.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

Authors:  Jeremy L Goodin; David F Nellis; Bradford S Powell; Vinay V Vyas; Jeffrey T Enama; Lena C Wang; Patrick K Clark; Steven L Giardina; Jeffery J Adamovicz; Dennis F Michiel
Journal:  Protein Expr Purif       Date:  2006-12-31       Impact factor: 1.650

2.  P19-dependent and P19-independent reversion of F1-V gene silencing in tomato.

Authors:  M Lucrecia Alvarez; Heidi L Pinyerd; Emel Topal; Guy A Cardineau
Journal:  Plant Mol Biol       Date:  2008-06-05       Impact factor: 4.076

3.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

Review 4.  Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.

Authors:  Ruth Elena Soria-Guerra; Leticia Moreno-Fierros; Sergio Rosales-Mendoza
Journal:  Plant Cell Rep       Date:  2011-04-20       Impact factor: 4.570

Review 5.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

6.  A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Authors:  Jian Sha; Michelle L Kirtley; Curtis Klages; Tatiana E Erova; Maxim Telepnev; Duraisamy Ponnusamy; Eric C Fitts; Wallace B Baze; Satheesh K Sivasubramani; William S Lawrence; Igor Patrikeev; Jennifer E Peel; Jourdan A Andersson; Elena V Kozlova; Bethany L Tiner; Johnny W Peterson; David McWilliams; Snehal Patel; Eric Rothe; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

7.  Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Authors:  Wei Sun; Kenneth L Roland; Xiaoying Kuang; Christine G Branger; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Higher accumulation of F1-V fusion recombinant protein in plants after induction of protein body formation.

Authors:  M Lucrecia Alvarez; Emel Topal; Federico Martin; Guy A Cardineau
Journal:  Plant Mol Biol       Date:  2009-09-30       Impact factor: 4.076

Review 9.  Oral transgenic plant-based vaccine for hepatitis B.

Authors:  Yasmin Thanavala; Amit A Lugade
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

10.  Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors:  Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.